CVS Health, UnitedHealth Group and Cigna sued the Federal Trade Commission, claiming the agency's case against drug middlemen over high insulin prices in the U.S. is unconstitutional.

UnitedHealth Group is also more diversified across multiple lines of business than CVS Health and Cigna are. The stock has delivered a total return of roughly 7.6x over the last 10 years.

The FTC sued UnitedHealth Group's Optum unit, CVS Caremark and Cigna's Express Scripts for allegedly steering diabetes patients towards higher priced insulin. Primary Menu Sections.

The FTC report showed that from 2017 to 2022, the three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds ...

CVS Health Corp. and UnitedHealth Group Inc. said members of the US Federal Trade Commission who voted to sue prescription drug middlemen should be barred from overseeing the case, alleging that ...

CVS Health and UnitedHealth Group have asked FTC Chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the ...

FTC accuses CVS, Cigna, and UnitedHealth of driving up insulin prices through rebates. PBMs administer 80% of U.S. prescriptions and allegedly inflate life-saving insulin costs. Market-moving news ...

UnitedHealth Group (NYSE:UNH), CVS Health (NYSE:CVS), and the Cigna Group (NYSE:CI) are asking that FTC Chair Lina Khan and two other commissioners recuse themselves from a case against pharmacy ...

UnitedHealth Group, CVS Health and Cigna are asking that Federal Trade Commission Chairwoman Lina Khan and two other commissioners recuse themselves from a lawsuit accusing the nation’s largest ...

The FTC didn’t challenge it because UnitedHealth didn’t compete in home health care at that time. UnitedHealth’s LHC Group has 964 locations in 37 states, ...

UnitedHealth Group is also more diversified across multiple lines of business than CVS Health and Cigna are. The stock has delivered a total return of roughly 7.6x over the last 10 years.